This population (or the analogous SLC52A2+NOTCH1+ population in scRNA-seq data), was also present in clinical NSCLC specimens before therapy, but innately resistant to chemotherapy and immunotherapy. The gene discussed is SLC52A2; the disease is non-small cell lung carcinoma.